Alcon Set to Acquire Summit Autonomous

FORT WORTH, Texas, June 1 -- Alcon has reported a forthcoming agreement to purchase Summit Autonomous Inc. of Waltham Mass. for $19.00 per share. Summit Autonomous Inc. is a manufacturer of ophthalmic laser systems designed to correct common vision disorders. According to Alcon this acquisition will fulfill its commitment to enter the refractive surgical market.
Our comprehensive global technological review, and, above all, the advice of top refractive surgeons, led us to the firm conviction that Summit Autonomous is the clear technological leader in the refractive field, said Tim Sear, Alcon's president and CEO. I am confident that the combination of Alcon's powerful, worldwide surgical sales and marketing organization with the highly skilled Summit Autonomous team will be in the best interest of both surgeons and patients.
Based in Fort Worth, Texas, Alcon employs over 10,000 people worldwide in the research, development, marketing and manufacturing of ophthalmic products. It is a subsidiary of Nestle SA.